You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. We no longer send these by email as we did in the past, but we post this and all of the newsletters on our website here.
Friends,
The Global Cannabis Stock Index closed on 2/11 at 5.69, which is down 3.4% in February and down 13.7% so far in 2026. Since April 30, 2024, it has plunged 51.4%. Five years ago, the index peaked at 92.48, and it has dropped 93.9% since then.
Many people pay attention to AdvisorShares Pure US Cannabis ETF (NYSE Arca: MSOS), and it is down 16.1% so far in 2026, and the drop since 4/30/24 has been a massive 64.8% to its current $3.96. It is just slightly higher than the $3.81 where it ended 2024, and it is up a lot from the all-time low set in April last year at $2.02. The ETF currently has about 2/3 of its portfolio in just three MSOs. Including the four other positions in excess of 5%, the top 7 represent 93.6% of MSOS.
Cannabis stocks are clearly under pressure. The 27 stocks in the Global Cannabis Stock Index are mainly down, though two of the stocks have rallied more than 15%, Scotts Miracle-Gro and Turning Point Brands. Neither of these two companies are catering exclusively to the cannabis industry. 7 stocks have dropped more than 20%, with three of them down more than 44%.
A few companies reported the quarters ending 12/31, but most of the companies in the index had years ending them and will report beginning later this month. I will share a preview ahead of then. I don’t think that the financial reports are what it will take to get things going for cannabis stocks. Instead, it requires rescheduling, which would result in the end of 280E taxation, which I have been discussing in this weekly newsletter since late 2022. The good news is that it is still potentially alive. I continue to suggest that one should not assume it will happen. It should happen, and it will be good if it happens. Good luck to all consumers, medical patients, industry workers and investors!
Sincerely,
Alan
New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we published this past 2 weeks:
Exclusives
Cannabis Sales Slipped in January
Cannabis Stocks Begin 2026 Badly
Illinois Provides Another Cannabis Update
Capital Raises
Canadian LP Decibel Extends Debt
Trulieve Borrows Another $60 Million
To get real-time updates, follow Alan on X.com. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.
View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks.
Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor calendar.
